A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
Clinical trial NCT02779751 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02779751
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-14
- Primary completion
- 2020-02-03
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.